Recent discoveries in autism research and epigenetics could soon make a clinical difference for children with attention-deficit/hyperactivity disorder, autism spectrum disorder, and other conditions, according to an expert. The implications go beyond targeting treatment for an individual child in your practice based on a specific genetic mutation, Dr. Hakon Hakonarson, director of the center for […]
Author Archives: Annie
Fragile X and Autism Expert Speaks on Autism in Jerusalem: The Fragile X Syndrome is the most common inherited cause of intellectual disability. Fragile X has a population incidence of approximately 1 in 4,000 affected (full-mutation) males, 1 in 6,000 affected females, 1 in 700 premutation carrier males and 1 in 260 carrier females. This disorder […]
Autism Conference Address: Bridging the Gap Between Families and Therapists: One of the most challenging, sensitive and complex treatment modes when working with children on the autistic spectrum is the home intervention program. This is a behavioral approach which actually takes place in the home of the child with special needs (this program is also known […]
Dr. Eli Hatchwell is the Chief Scientific Officer and co-founder of Population Diagnostics and has engaged in genetic research for 20 years including as an Investigator at Cold Spring Harbor Laboratory and, most recently, an Associate Professor and Director of the Genomics Core Facility at SUNY at Stony Brook.
A study led by Dr. Eric Hollander, Director of the Autism Spectrum Program at Albert Einstein College of Medicine/Montefiore Medical Center and Chairman of the ICare4Autism Advisory Council found the antidepressant fluoxetine alleviated repetitive behavior and obsessive-compulsive symptoms in adults with autism, reducing these defining symptoms of the disorder. Dr. Hollander will be speaking on […]